ARCHIVES

Cancel Panel Activity Ceases Due To Hammer’s Death; Oxy Chairman Promoted Funding Of Research

This article is from The Cancer Letter archive.

Vol. 17 No. 01 | January 4, 1991

Download PDF Visit The Full Archive

Related Articles

North Central Group Review Postponed While New Committee Formed To Handle All “Regional: Groups

July 10, 1981

FDA Approves Folotyn For Peripheral T-Cell Lymphoma

September 25, 2009

Ibrutinib Demonstrates 71% ORR In Phase Ib/II CLL and SLL Study

July 26, 2013

New Staff Proposals For Comprehensive Center Recognition Considered By NCAB

January 19, 1979

In Brief: Obey Was Right- Tests On 70 Chemical Would Have Been Aborted Under NCI Budget

July 20, 1979

DOD Breast Cancer Program Releases Research Solicitation

October 1, 1993